Brief

Teva Settles Claims Over Delayed Generic Asthma Inhalers

By Julie Manganis · August 5, 2025, 3:17 PM EDT

Teva Pharmaceuticals has settled a 2023 lawsuit by a coalition of union healthcare funds accusing the company of thwarting the introduction of a generic version of its QVAR inhalers to the...

To view the full article, register now.